Ironwood (IRWD) Updates on Q3 Activity; FDA Approves LINZESS, Linaclotide Gets Nod from CHMP

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Ironwood (IRWD) Updates on Q3 Activity; FDA Approves LINZESS, Linaclotide Gets Nod from CHMP

Ironwood Pharma (IRWD) Tops Q3 EPS by 29c

October 16, 2012 7:12 AM EDT

Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.42, $0.29 better than the analyst estimate of $0.13. Revenue for the quarter came in at $96.4 million versus the consensus estimate of $75.9 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.... More